Dorman Followwill - Net Worth and Insider Trading
Dorman Followwill Net Worth
The estimated net worth of Dorman Followwill is at least $1,170 dollars as of 2024-12-14. Dorman Followwill is the Director of Scilex Holding Co and owns about 2,300 shares of Scilex Holding Co (SCLX) stock worth over $1,167. Dorman Followwill is also the Director of Sorrento Therapeutics Inc and owns about 2,130 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $3. Details can be seen in Dorman Followwill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dorman Followwill has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dorman Followwill
Dorman Followwill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dorman Followwill owns 2 companies in total, including Sorrento Therapeutics Inc (SRNE) , and Scilex Holding Co (SCLX) .
Click here to see the complete history of Dorman Followwill’s form 4 insider trades.
Insider Ownership Summary of Dorman Followwill
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SRNE | Sorrento Therapeutics Inc | 2020-12-16 | director |
SCLX | Scilex Holding Co | 2024-10-18 | director |
Dorman Followwill Latest Holdings Summary
Dorman Followwill currently owns a total of 2 stocks. Among these stocks, Dorman Followwill owns 2,300 shares of Scilex Holding Co (SCLX) as of October 18, 2024, with a value of $1,167 and a weighting of 99.73%. Dorman Followwill also owns 2,130 shares of Sorrento Therapeutics Inc (SRNE) as of December 16, 2020, with a value of $3 and a weighting of 0.27%.
Latest Holdings of Dorman Followwill
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SCLX | Scilex Holding Co | 2024-10-18 | 2,300 | 0.51 | 1,167 |
SRNE | Sorrento Therapeutics Inc | 2020-12-16 | 2,130 | 0.00 | 3 |
Holding Weightings of Dorman Followwill
Dorman Followwill Form 4 Trading Tracker
According to the SEC Form 4 filings, Dorman Followwill has made a total of 1 transactions in Scilex Holding Co (SCLX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Scilex Holding Co is the acquisition of 1,000 shares on October 18, 2024, which cost Dorman Followwill around $990.
According to the SEC Form 4 filings, Dorman Followwill has made a total of 1 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sorrento Therapeutics Inc is the sale of 1,000 shares on December 16, 2020, which brought Dorman Followwill around $7,140.
Insider Trading History of Dorman Followwill
- 1
Dorman Followwill Trading Performance
GuruFocus tracks the stock performance after each of Dorman Followwill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dorman Followwill is %. GuruFocus also compares Dorman Followwill's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dorman Followwill within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dorman Followwill's insider trading performs compared to the benchmark.
Performance of Dorman Followwill
Dorman Followwill Ownership Network
Ownership Network List of Dorman Followwill
Ownership Network Relation of Dorman Followwill
Dorman Followwill Owned Company Details
What does Sorrento Therapeutics Inc do?
Who are the key executives at Sorrento Therapeutics Inc?
Dorman Followwill is the director of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .
Sorrento Therapeutics Inc (SRNE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sorrento Therapeutics Inc Insider Transactions
Dorman Followwill Mailing Address
Above is the net worth, insider trading, and ownership report for Dorman Followwill. You might contact Dorman Followwill via mailing address: C/o Sorrento Therapeutics, Inc., 4955 Director's Place, San Diego Ca 92121.